古吉拉特肾脏首次公开募股（IPO）首发便飙升6%，筹集了2.51亿卢比，零售需求强劲。 Gujarat Kidney's IPO surged 6% on debut, raising ₹251 crore with strong retail demand.

古吉拉特肾脏与超级特种有限公司于2025年12月30日强势市场亮相，股价上涨近6%，高于首次公开募股价₹114，BSE开盘价为₹120.75，NSE为₹120。 Gujarat Kidney and Super Speciality Ltd. made a strong market debut on December 30, 2025, with shares rising nearly 6% above the IPO price of ₹114, opening at ₹120.75 on BSE and ₹120 on NSE. 由于零售需求强, 印度251亿美元的IPO获得了5.21倍的订阅. The ₹251 crore IPO, fully a fresh issue, saw 5.21 times subscription, driven by robust retail demand. 收益将用于购置医院、建造新设施、购置设备和偿还债务。 Proceeds will fund hospital acquisitions, new facility construction, equipment purchases, and debt repayment. 该公司在古吉拉特经营七所多专科医院,有490张床位,重点是肾脏和超级专科护理。 The company operates seven multi-specialty hospitals in Gujarat with 490 beds, focusing on renal and super-specialty care.